
GlaxoSmithKline has made good on a pledge to invest in UK-based production, with £200 million ($328m) earmarked for plant upgrades …
The deaths of dozens of patients as a result of the contaminated heparin incident in 2008 casts a long shadow …

Merck KGaA and Johnson & Johnson have both announced new manufacturing projects in China, suggesting investigations into corruption by the …

Eli Lilly has said it will invest more than $700 million to expand its production capacity for insulin products in …
GlaxoSmithKline is planning to boost in-house production of pharmaceuticals in India by building a brand new facility with an investment …

The European Medicines Agency has issued draft guidance to help drug manufacturers avoid cross-contamination of products made in shared facilities. …

Teva’s recent announcement of a major restructuring of its business to cut costs and maintain profitability includes a revamp of …

Non-precious metals such as copper could be used as catalysts in pharmaceuticals production, replacing precious metals that are expensive and …

Novasep has announced the appointment of Roger-Marc Nicoud, founder and chief executive, as non-executive chairman of the Board. The manufacturing …
The global contract manufacturing market is expected to reach a value of nearly $48 billion this year on the back …
Changes to the EU’s rules governing the importation of active pharmaceutical ingredients (APIs) are being opposed by the governments of …